BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

634 related articles for article (PubMed ID: 34956899)

  • 21. Long noncoding RNA UCA1 promotes osteosarcoma metastasis through CREB1-mediated epithelial-mesenchymal transition and activating PI3K/AKT/mTOR pathway.
    Ma H; Su R; Feng H; Guo Y; Su G
    J Bone Oncol; 2019 Jun; 16():100228. PubMed ID: 31011522
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Single-Cell Profiling of Tumor Microenvironment Heterogeneity in Osteosarcoma Identifies a Highly Invasive Subcluster for Predicting Prognosis.
    Guo J; Tang H; Huang P; Guo J; Shi Y; Yuan C; Liang T; Tang K
    Front Oncol; 2022; 12():732862. PubMed ID: 35463309
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Natural compounds targeting major cell signaling pathways: a novel paradigm for osteosarcoma therapy.
    Angulo P; Kaushik G; Subramaniam D; Dandawate P; Neville K; Chastain K; Anant S
    J Hematol Oncol; 2017 Jan; 10(1):10. PubMed ID: 28061797
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Application of Long Noncoding RNAs in Osteosarcoma: Biomarkers and Therapeutic Targets.
    Li Z; Dou P; Liu T; He S
    Cell Physiol Biochem; 2017; 42(4):1407-1419. PubMed ID: 28715796
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Osteosarcoma Microenvironment: A Complex But Targetable Ecosystem.
    Corre I; Verrecchia F; Crenn V; Redini F; Trichet V
    Cells; 2020 Apr; 9(4):. PubMed ID: 32326444
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Managing the immune microenvironment of osteosarcoma: the outlook for osteosarcoma treatment.
    Tian H; Cao J; Li B; Nice EC; Mao H; Zhang Y; Huang C
    Bone Res; 2023 Feb; 11(1):11. PubMed ID: 36849442
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PLA2G16 Expression in Human Osteosarcoma Is Associated with Pulmonary Metastasis and Poor Prognosis.
    Liang S; Ren Z; Han X; Yang J; Shan L; Li L; Wang B; Zhang Q; Mu T; Chen K; Xiong S; Wang G
    PLoS One; 2015; 10(5):e0127236. PubMed ID: 25993412
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular alterations as target for therapy in metastatic osteosarcoma: a review of literature.
    PosthumaDeBoer J; Witlox MA; Kaspers GJ; van Royen BJ
    Clin Exp Metastasis; 2011 Jun; 28(5):493-503. PubMed ID: 21461590
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Wnt signaling in osteosarcoma.
    Lin CH; Ji T; Chen CF; Hoang BH
    Adv Exp Med Biol; 2014; 804():33-45. PubMed ID: 24924167
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Strategies to explore new approaches in the investigation and treatment of osteosarcoma.
    Kim SY; Helman LJ
    Cancer Treat Res; 2009; 152():517-28. PubMed ID: 20213413
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Key genes with prognostic values in suppression of osteosarcoma metastasis using comprehensive analysis.
    Li M; Jin X; Li H; Wu G; Wang S; Yang C; Deng S
    BMC Cancer; 2020 Jan; 20(1):65. PubMed ID: 31992246
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targetable Intercellular Signaling Pathways Facilitate Lung Colonization in Osteosarcoma.
    Reinecke JB; Roberts RD
    Adv Exp Med Biol; 2020; 1258():111-123. PubMed ID: 32767237
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Osteosarcoma: Accelerating Progress Makes for a Hopeful Future.
    Saraf AJ; Fenger JM; Roberts RD
    Front Oncol; 2018; 8():4. PubMed ID: 29435436
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overexpression of smad7 blocks primary tumor growth and lung metastasis development in osteosarcoma.
    Lamora A; Talbot J; Bougras G; Amiaud J; Leduc M; Chesneau J; Taurelle J; Stresing V; Le Deley MC; Heymann MF; Heymann D; Redini F; Verrecchia F
    Clin Cancer Res; 2014 Oct; 20(19):5097-112. PubMed ID: 25107916
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long noncoding RNAs in the progression, metastasis, and prognosis of osteosarcoma.
    Yang Z; Li X; Yang Y; He Z; Qu X; Zhang Y
    Cell Death Dis; 2016 Sep; 7(9):e2389. PubMed ID: 27685633
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nano-Based Drug Delivery Systems: Potential Developments in the Therapy of Metastatic Osteosarcoma-A Narrative Review.
    Luo Y; Sun M; Tan L; Li T; Min L
    Pharmaceutics; 2023 Dec; 15(12):. PubMed ID: 38140058
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MiRNA-206 suppresses the metastasis of osteosarcoma via targeting Notch3.
    Cai WT; Guan P; Lin MX; Fu B; Wu B; Wu J
    J Biol Regul Homeost Agents; 2020; 34(3):775-783. PubMed ID: 32627519
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long noncoding RNA DANCR, working as a competitive endogenous RNA, promotes ROCK1-mediated proliferation and metastasis via decoying of miR-335-5p and miR-1972 in osteosarcoma.
    Wang Y; Zeng X; Wang N; Zhao W; Zhang X; Teng S; Zhang Y; Lu Z
    Mol Cancer; 2018 May; 17(1):89. PubMed ID: 29753317
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Current and Future Therapies for Human Osteosarcoma.
    Lamplot JD; Denduluri S; Qin J; Li R; Liu X; Zhang H; Chen X; Wang N; Pratt A; Shui W; Luo X; Nan G; Deng ZL; Luo J; Haydon RC; He TC; Luu HH
    Curr Cancer Ther Rev; 2013 Feb; 9(1):55-77. PubMed ID: 26834515
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of prognostic biomarkers associated with metastasis and immune infiltration in osteosarcoma.
    Yang B; Su Z; Chen G; Zeng Z; Tan J; Wu G; Zhu S; Lin L
    Oncol Lett; 2021 Mar; 21(3):180. PubMed ID: 33574919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.